1. Home
  2. ATNM vs VTSI Comparison

ATNM vs VTSI Comparison

Compare ATNM & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.40

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.87

Market Cap

61.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
VTSI
Founded
2000
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
61.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
VTSI
Price
$1.40
$4.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$7.00
AVG Volume (30 Days)
194.8K
60.4K
Earning Date
11-14-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$90,000.00
$24,934,267.00
Revenue This Year
N/A
N/A
Revenue Next Year
$42,943.57
$13.39
P/E Ratio
N/A
$344.20
Revenue Growth
11.11
N/A
52 Week Low
$1.03
$3.57
52 Week High
$2.41
$7.49

Technical Indicators

Market Signals
Indicator
ATNM
VTSI
Relative Strength Index (RSI) 51.02 41.61
Support Level $1.33 $4.79
Resistance Level $1.54 $5.13
Average True Range (ATR) 0.09 0.20
MACD 0.01 0.04
Stochastic Oscillator 56.90 44.08

Price Performance

Historical Comparison
ATNM
VTSI

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: